Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mauck, Matt
BEST, NCT05396014: The Trial: Biomarkers for Evaluating Spine Treatments	Completed	4	1014	US	Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta	University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Chronic Low-back Pain	07/24	10/24
VENTURE, NCT05458024: Vitamin D to ENhance TraUma REcovery	Completed	2	71	US	Vitamin D 2, Ergocalciferol 300,000 IU, Vitamin D2 Placebo, Ergocalciferol Placebo	University of North Carolina, Chapel Hill, National Institute on Minority Health and Health Disparities (NIMHD)	Musculoskeletal Pain	05/24	05/24
Chidgey, Brooke
BEST, NCT05396014: The Trial: Biomarkers for Evaluating Spine Treatments	Completed	4	1014	US	Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta	University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Chronic Low-back Pain	07/24	10/24
Asante-Nketiah, Bernice
BEST, NCT05396014: The Trial: Biomarkers for Evaluating Spine Treatments	Completed	4	1014	US	Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta	University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Chronic Low-back Pain	07/24	10/24